1-888-825-SDSF (7373)

SDSF is Investing in Research

We are proud to announce that SDSF is investing in research by Dr. Corey and his laboratory to investigate the cellular stress responses associated with Shwachman-Diamond Syndrome and explore potential approaches to preventing disease progression and serious complications.

This research represents an important step in our mission to support scientific discoveries that can lead to better treatments and, ultimately, a cure.

 Dr. Corey has provided the following explanation of his research and its potential impact:

The most feared complication of Shwachman-Diamond syndrome is its transformation to a blood cancer, such as myelodysplastic syndrome or acute leukemia. For years, studying SDS has been difficult because patients are few and complications take a long time to develop. The Corey lab has addressed this by developing organismal models, such as the zebrafish and yeast lacking SDS protein. When cells lack the normal SDS protein, their ribosomes malfunction, triggering severe internal stress. Performing genetic and biochemistry studies, the Corey lab has zeroed in on identifying and characterizing these stress responses. Using zebrafish, they have identified activation of P53 stress damage responses. However, when the Corey lab made fish lacking both SBDS and P53, the fish did not become healthier. What is also notable is that yeast do not carry P53, and so the abnormalities in SDS cells cannot be entirely due to P53. Using yeast, human cells that lack the SDS protein, and patient-derived blood cells, they have identified p38, a stress activated protein kinase. (A kinase is an enzyme that changes the behavior of cells.) Because developing entirely new drugs is expensive and time-consuming, Corey and his collaborators are focusing on repurposing existing medications that target this chronic stress pathway. By blocking specific stress responses, Corey hopes that these drugs can prevent SDS disease progression in all tissues and prevent its transformation to blood cancers and other late complications.

At the Shwachman-Diamond Syndrome Foundation, our mission goes beyond raising awareness. We are actively investing in research that advances scientific understanding, explores new treatment possibilities, and brings us closer to a better future for everyone living with SDS.

Through research, collaboration, and an unwavering commitment to the SDS community, we are working to change the future of Shwachman-Diamond Syndrome.

About Shwachman-Diamond Syndrome Foundation

Shwachman Diamond Syndrome Foundation was founded in 1994 by Joan Mowery, a mother of an SDS patient. Shwachman-Diamond Syndrome Foundation is a national, not-for-profit, patient advocacy organization. Our goals are to advocate and fund research towards improved treatment and a cure.

We provide educational services and emotional support to SDS families. We sponsor a bi-annual family conference which allows patients and their families the opportunity to hear and speak to members of our Medical/Scientific Medical Board, who are experts in various aspects of SDS. We are also proud sponsors of the Shwachman-Diamond Syndrome International Scientific Congress which brings together physicians and scientists from around the world to share the most recent information on SDS. And we support the North American SDS Patient Registry.

We continually strive to raise awareness of SDS in both the medical community and the general population. To learn more, visit https://shwachman-diamond.org/. 

Call Now Button Skip to content